2019
DOI: 10.3389/fimmu.2019.02845
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative Mass Spectrometric Analysis of Autoantibodies as a Paradigm Shift in Autoimmune Serology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 31 publications
(34 reference statements)
0
10
0
Order By: Relevance
“…Mass spectrometry is being increasingly adopted to study the molecular composition of proteins such as autoantibodies. 47 Analysis of the heavy and light chains of precipitating anti-dsDNA has been performed showing stereotyped heavy and light chain usage with shared mutations. 48 This suggests a common origin for these autoantibodies and may provide an opportunity for understanding the origin and pathogenicity of these autoantibodies beyond the isotype.…”
Section: Discussionmentioning
confidence: 99%
“…Mass spectrometry is being increasingly adopted to study the molecular composition of proteins such as autoantibodies. 47 Analysis of the heavy and light chains of precipitating anti-dsDNA has been performed showing stereotyped heavy and light chain usage with shared mutations. 48 This suggests a common origin for these autoantibodies and may provide an opportunity for understanding the origin and pathogenicity of these autoantibodies beyond the isotype.…”
Section: Discussionmentioning
confidence: 99%
“…As some of the most important biomarkers in autoimmunity, 17 the appearance of autoantibodies and why GA become the target of autoantibodies is not clear. It is possible that during excess cell apoptosis, these cytoplasmic structures become cleaved and exposed, creating neoantigens for targeting 3 .…”
Section: Discussionmentioning
confidence: 99%
“…In the changing landscape of autoimmune diagnostics, there is a greater need to provide better tailored information for the clinician and patient, and MS may contribute to this effort (16). It is conceivable that, through further study, it may be possible to establish which subfamilies correlate with clinical parameters and offer differential prognostic data.…”
Section: Figurementioning
confidence: 99%